Biostatistic Expertise

Biostatistics is the driving force underlying every clinical trial. At each step of the way — from designing the trial to analyzing data to interpreting the results — biostatisticians can improve efficiency and speed your drug to market. Essentially, it's the numbers that will tell your compound's story, demonstrating a drug's efficacy or safety.

Biostatistics is also at the core of Quintiles. Starting with our first projects in 1982, our pioneering expertise in analyzing and reporting data helped create the biopharma services industry and continues to set the standard. To us, biostatistics isn't just another service; it's the key that unlocks new possibilities for smarter trial design, streamlined clinical studies and higher quality submissions.

Learn how we are redefining the role of biostatistics in the New Health. Explore our latest publications and presentations below.

Speeding Drug Development
As regulatory challenges mount and budgets shrink, drug sponsors can't depend on yesterday's clinical trial processes. You need innovative approaches to design, analysis and reporting to streamline your path to market. Biostatistics can help.

Defining Best Practices in Biostatistics
The rules are evolving as fast as the market. How can you keep pace with up-to-the-minute standards? Learn what's working — and what isn't — from the leading names in the industry.

Overcoming Statistical Challenges
Driven by concerns from operational bias to the sheer complexity of testing today's new compounds, regulators are scrutinizing data more closely than ever. Biostatistics will help navigate your challenges.

Qualifying Biomarkers
What could bring together competitors in the drug industry to work toward a common goal? The development and qualification of biomarkers is key to the future of drug development and personalized medicine, and collaboration is critical to advancing the field. Biostatistics is playing a key role in this research.